Please assess the completion status of the following clinical trial:

Trial Title: S.A.F.E.BT System Extracorporeal Treatment With DIAPACT CRRT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Clinical diagnosis of Sepsis~* Mechanical ventilation due to acute pulmonary dysfunction~* One additional (second) acute sepsis-related organ dysfunction~Exclusion Criteria~* Pregnant women and nursing mothers~* Conditions or medications associated with an increased risk of bleeding/complications from anticoagulation~* Previous episode of sepsis during this hospitalization~* PaO2/FiO2 ratio \< 300~* Severe granulocytopenia (leukocytes \<500 / μl)~* Acute hepatic diseases or severe liver failure or cirrhosis~* Chronic cardiovascular disease precluding extracorporeal treatment~* Human immunodeficiency virus complicated by AIDS defining illness~* Evidence of active bleeding - uncontrolled hemorrhage

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): S.A.F.E.BT plus Standard of Care therapy
- Group B (Type: NO_INTERVENTION): Standard of Care therapy alone

Based on this trial design, predict the completion outcome and termination type (if applicable).